000303953 001__ 303953
000303953 005__ 20250821114622.0
000303953 0247_ $$2doi$$a10.1093/jncimonographs/lgaf029
000303953 0247_ $$2pmid$$apmid:40828162
000303953 0247_ $$2ISSN$$a1052-6773
000303953 0247_ $$2ISSN$$a1745-6614
000303953 037__ $$aDKFZ-2025-01728
000303953 041__ $$aEnglish
000303953 082__ $$a610
000303953 1001_ $$00000-0001-6250-0041$$aZopf, Eva M$$b0
000303953 245__ $$aConsiderations for delivery of live-remote exercise for people with cancer in research and practice.
000303953 260__ $$aOxford$$bOxford Univ. Press$$c2025
000303953 3367_ $$2DRIVER$$aarticle
000303953 3367_ $$2DataCite$$aOutput Types/Journal article
000303953 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1755758258_3180
000303953 3367_ $$2BibTeX$$aARTICLE
000303953 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303953 3367_ $$00$$2EndNote$$aJournal Article
000303953 520__ $$aExercise is safe and beneficial for people diagnosed with cancer. The use of live-remote exercise approaches, where exercise trainers deliver exercise programs via a videoconferencing platform, has increased rapidly, greatly expanding the reach of exercise programs. This method retains key elements of supervised exercise, which provide greater benefits than unsupervised programs. However, challenges in adapting in-person supervised exercise programs to remote delivery exist. This article discusses the key considerations for the effective and safe delivery of live-remote exercise, such as technological requirements, exercise professional skills, safety aspects, exercise programming features, social interactions, costs, and legal and ethical considerations. Considerations relevant for the design and execution of exercise oncology clinical trials and for community practice are described. Remaining knowledge gaps are outlined and point to opportunities to further inform evidence-based practice and practice-based evidence.
000303953 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000303953 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303953 7001_ $$aMüller, Jana$$b1
000303953 7001_ $$aTrevaskis, Mark$$b2
000303953 7001_ $$0P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6$$aKias, Alina$$b3$$udkfz
000303953 7001_ $$aHiensch, Anouk E$$b4
000303953 7001_ $$aBland, Kelcey A$$b5
000303953 7001_ $$aLorenz, Maria C$$b6
000303953 7001_ $$aMonninkhof, Evelyn M$$b7
000303953 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina E$$b8$$udkfz
000303953 7001_ $$aBinyam, David$$b9
000303953 7001_ $$0P:(DE-He78)f52b77d7ab843c9b900134aafc61638a$$aClauss, Dorothea$$b10$$udkfz
000303953 7001_ $$aGunasekara, Nadira$$b11
000303953 7001_ $$aCrisafio, Mary$$b12
000303953 7001_ $$aDe Jongh, Esther$$b13
000303953 7001_ $$aOlivier, Franziska$$b14
000303953 7001_ $$aWengström, Yvonne$$b15
000303953 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b16$$udkfz
000303953 7001_ $$aAlves, Alberto J C$$b17
000303953 7001_ $$aCampbell, Anna$$b18
000303953 7001_ $$aCampbell, Kristin L$$b19
000303953 7001_ $$aStuiver, Martijn M$$b20
000303953 7001_ $$aMay, Anne M$$b21
000303953 7001_ $$00000-0003-1706-8020$$aWinters-Stone, Kerri$$b22
000303953 773__ $$0PERI:(DE-600)2044141-1$$a10.1093/jncimonographs/lgaf029$$gVol. 2025, no. 71, p. 351 - 359$$n71$$p351 - 359$$tJournal of the National Cancer Institute / Monographs$$v2025$$x1052-6773$$y2025
000303953 909CO $$ooai:inrepo02.dkfz.de:303953$$pVDB
000303953 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000303953 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000303953 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f52b77d7ab843c9b900134aafc61638a$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000303953 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000303953 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000303953 9141_ $$y2025
000303953 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-12$$wger
000303953 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-12
000303953 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-12
000303953 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-12
000303953 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-12
000303953 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-12
000303953 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Krebsprävention und Survivorship$$x0
000303953 980__ $$ajournal
000303953 980__ $$aVDB
000303953 980__ $$aI:(DE-He78)C110-20160331
000303953 980__ $$aUNRESTRICTED